These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11122781)

  • 41. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.
    Hirata-Dulas CA; Rith-Najarian SJ; McIntyre MC; Ross C; Dahl DC; Keane WF; Kasiske BL
    Clin Nephrol; 1996 Aug; 46(2):92-8. PubMed ID: 8869785
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study.
    Jahangiri-Noudeh Y; Akbarpour S; Lotfaliany M; Zafari N; Khalili D; Tohidi M; Mansournia MA; Azizi F; Hadaegh F
    PLoS One; 2014; 9(12):e112639. PubMed ID: 25461381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the Framingham Heart Study.
    Andersson C; Lyass A; Vasan RS; Massaro JM; D'Agostino RB; Robins SJ
    Am Heart J; 2014 Dec; 168(6):878-83.e1. PubMed ID: 25458651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma lipoproteins and the incidence of abnormal excretion of albumin in diabetic American Indians: the Strong Heart Study.
    Fagot-Campagna A; Nelson RG; Knowler WC; Pettitt DJ; Robbins DC; Go O; Welty TK; Lee ET; Howard BV
    Diabetologia; 1998 Sep; 41(9):1002-9. PubMed ID: 9754817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes.
    Li TY; Brennan AM; Wedick NM; Mantzoros C; Rifai N; Hu FB
    J Nutr; 2009 Jul; 139(7):1333-8. PubMed ID: 19420347
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetic dyslipidemia.
    Kreisberg RA
    Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discordance between lipid markers used for predicting cardiovascular risk in patients with type 2 diabetes.
    Modi KD; Chandwani R; Ahmed I; Kumar KV
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S99-S102. PubMed ID: 26589777
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.
    Franzini L; Ardigò D; Cavalot F; Miccoli R; Rivellese AA; Trovati M; Zavaroni I; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):235-41. PubMed ID: 22397873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).
    Russell M; Fleg JL; Galloway WJ; Henderson JA; Howard J; Lee ET; Poolaw B; Ratner RE; Roman MJ; Silverman A; Stylianou M; Weir MR; Wilson C; Yeh F; Zhu J; Howard BV
    Am Heart J; 2006 Nov; 152(5):867-75. PubMed ID: 17070147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Change in high-density lipoprotein cholesterol and risk of subsequent hospitalization for coronary artery disease or stroke among patients with type 2 diabetes mellitus.
    Nichols GA; Vupputuri S; Rosales AG
    Am J Cardiol; 2011 Oct; 108(8):1124-8. PubMed ID: 21985949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China.
    Ouyang XJ; Zhang YQ; Chen JH; Li T; Lu TT; Bian RW
    Chin Med J (Engl); 2018 Feb; 131(3):295-300. PubMed ID: 29363644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
    Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
    Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry.
    Yang X; So WY; Ma RC; Kong AP; Lee HM; Xu G; Ozaki R; Chan JC
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S185-93. PubMed ID: 22722949
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
    Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
    Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
    Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
    Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LDL cholesterol is not a good marker of cardiovascular risk in Type 1 diabetes.
    Hero C; Svensson AM; Gidlund P; Gudbjörnsdottir S; Eliasson B; Eeg-Olofsson K
    Diabet Med; 2016 Mar; 33(3):316-23. PubMed ID: 26498834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis.
    Navarro JF; Mora C; Muros M; García-Idoate G
    Nephron Clin Pract; 2003; 95(4):c128-35. PubMed ID: 14694274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.